Newbury Pharmaceuticals AB Working Capital to Net Assets Ratio
Newbury Pharmaceuticals AB working capital to net assets ratio. Newbury Pharmaceuticals AB (NEWBRY) has a Working Capital to Net Assets ratio of 15.6% as of February 2026. Working capital of Skr4.88 Million (current assets of Skr47.23 Million minus current liabilities of Skr42.35 Million) is measured against net assets of Skr31.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Newbury Pharmaceuticals AB (NEWBRY) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Newbury Pharmaceuticals AB (2021–2024)
Working capital to net assets ratio of Newbury Pharmaceuticals AB from 2021 to 2024. This chart shows how Newbury Pharmaceuticals AB's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of February 2026, the ratio stands at 15.6%, reflecting working capital of Skr4.88 Million against net assets of Skr31.30 Million SEK. See Newbury Pharmaceuticals AB defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Newbury Pharmaceuticals AB Working Capital to Net Assets Ratio by Year (2021–2024)
Newbury Pharmaceuticals AB working capital to net assets ratio by year from 2021 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Newbury Pharmaceuticals AB from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NEWBRY total asset value.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 28.0% | Skr14.53 Million | Skr51.92 Million | Skr43.97 Million | Skr29.45 Million | ▼ -3.3 pp |
| 2023 | 31.3% | Skr15.47 Million | Skr49.38 Million | Skr27.24 Million | Skr11.77 Million | ▼ -12.9 pp |
| 2022 | 44.2% | Skr30.41 Million | Skr68.77 Million | Skr36.47 Million | Skr6.06 Million | ▲ +14.5 pp |
| 2021 | 29.7% | Skr11.43 Million | Skr38.47 Million | Skr15.77 Million | Skr4.34 Million | — |